Have You Heard? A new treatment option for feline cytauxzoonosis

Article

A recent study examined two treatment options for the tick-borne illness.

A recent study examined two treatment options for the tick-borne illness.

Cohn LA, Birkenheuer AH, Brunker JD, et al. Efficacy of atovaquone and azithromycin or imidocarb dipropionate in cats with acute cytauxzoonosis.

J Vet Intern Med

2011;25:55-60.

Click here

for link to the full text of the article.

Newsletter

From exam room tips to practice management insights, get trusted veterinary news delivered straight to your inbox—subscribe to dvm360.

Subscribe Now!
Recent Videos
Image Credit: © abet - stock.adobe.com
Related Content
Cat relaxing

The icteric cat: diagnosis and treatment of common feline hepatopathies

Kelly Cairns, DVM, MS, DACVIM (SAIM)
June 25th 2025
Article

Understanding feline cholangiohepatitis syndrome and hepatic lipidosis

Read More

What you should know about heartworm in cats and the updated AHS guidelines

What you should know about heartworm in cats and the updated AHS guidelines

Kelly D. Mitchell, DVM, DVSc., DACVIM;Caitlin McCafferty, Editor
May 16th 2025
Podcast

Learn more on heartworm in feline patients, plus what has been updated in the American Heartworm Society guidelines on this episode of The Vet Blast Podcast, presented by dvm360.

Listen

Study links older age to early mortality and treatment gaps in feline diabetes

Study links older age to early mortality and treatment gaps in feline diabetes

Abi Bautista-Alejandre, Assistant Editor
June 20th 2025
Article

The study, presented at the 2025 ACVIM Forum, found that cats aged greater than or equal to 15 years old were less likely to receive antihyperglycemic therapy.

Read More

Updates in treating FIP

Updates in treating FIP

Caitlin McCafferty, Editor
August 28th 2024
Podcast

Drs Adam Christman and Christopher Byers highlight recent FIP treatment advancements

Listen

British shorthair cat

Novel cardiology therapy for cats is launched

Kristen Coppock Crossley, MA
June 18th 2025
Article

Sirolimus delayed-release tablets (Felycin-CA1; PRN Pharmacal) has conditional approval from the FDA

Read More

The case for year-round heartworm prevention and how to talk with clients about affordable options

The case for year-round heartworm prevention and how to talk with clients about affordable options

Peter C. Hann, DVM
June 17th 2025
Article

Veterinary teams can help clients protect their pets from heartworm disease by offering compassionate guidance and affordable solutions, including safe and effective generic alternatives.

Read More

© 2025 MJH Life Sciences

All rights reserved.